Patent Foramen Ovale: Story Closed?

The optimal treatment strategy for secondary prevention in patients with cryptogenic stroke and patent foramen ovale (PFO) has been a matter of controversy for decades. After three randomized trials failed to show a benefit of closure with an excess of complications in the interventional arm, two la...

Descripción completa

Detalles Bibliográficos
Autores principales: Köhrmann, Martin, Schellinger, Peter D., Tsivgoulis, Georgios, Steiner, Thorsten
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Stroke Society 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372901/
https://www.ncbi.nlm.nih.gov/pubmed/30732440
http://dx.doi.org/10.5853/jos.2018.03097

Ejemplares similares

Ejemplares similares